Once again, Horizon had a successful return to the event, this time at SLAS2017. It was great to meet so many new prospective clients looking for genetically defined reagents.
A large proportion of talks during the event highlighted the opportunities provided by gene-editing technology, in particular CRISPR. Dr Lorenz Mayr, from Astra Zeneca, discussed the power of using genetics to predict cellular responses, and increase success for target identification. Gene engineering to create model systems for target validation was also widely discussed.
However, the buzz words were “endogenously tagged” cell lines, as these bring the advantages of studying promoter activity and protein localisation in live assays. Interestingly, we are now seeing how advances in imaging hardware, such as the Opera Phenix™ High Content Screening System, can maximize the information gained from endogenously tagged cell lines.
The prize for the most entertaining exhibit had to go to none other than the amazing Aquajelly from Festo, which showed the fun side of robotics.